A post hoc analysis of the STARMEN trial found that a combination of three early biomarkers can predict 2-year remission in ...

Biogen Inc. (($BIIB)) announced an update on their ongoing clinical study. Biogen Inc. is conducting a Phase 3 study titled ...

Retrospective cohort study. Data from all hospitalized pregnant women between 2009 and 2014 with new onset isolated proteinuria of over 300 mg/24 h at admission were obtained. Follow-up was performed ...

The APPLAUSE-IgAN results demonstrate that targeted, disease-modifying therapy can preserve long-term kidney function.

Please provide your email address to receive an email when new articles are posted on . At 36 weeks, patients receiving sparsentan experienced a mean 49.8% reduction in proteinuria from baseline.

Please provide your email address to receive an email when new articles are posted on . Including the duration of proteinuria remission may better predict which patients with IgA nephropathy will ...

Vera Therapeutics announced that its ORIGIN Phase 3 trial of atacicept for IgA nephropathy met its primary endpoint, showing statistically significant and clinically meaningful reductions in ...

Greater disease activity and higher proteinuria levels were associated with a greater risk for VTE among patients with LN.

Sudden cardiac arrest, while rare, was somewhat more likely for young adults whose lab values indicated proteinuria approximately 10 years prior. The findings were based on a study of 6.8 million ...

THE continuing function of transplanted kidneys depends on the development of a degree of "tolerance" between graft and recipient and the judicious use of immunosuppressive therapy to further this ...

As part of a community screening study to assess the long-term health outcomes among residents of Walkerton, Ontario, after contamination of its municipal water supply by Escherichia coli O157:H7 and ...